| 國立臺灣大學 |
1985 |
Predictive adaptive control system for unmeasured disturbances
|
Huang, Hsiao Ping; Chao, Yung Cheng; Liu, Pea Hsien |
| 國立交通大學 |
2016-03-28T00:05:42Z |
Predictive Analytics-Driven Campaign Management Support Systems
|
Goul, Michael; Balkan, Sule; Dolk, Dan |
| 國立成功大學 |
2012-08 |
PREDICTIVE AND CONSTRUCT VALIDITY OF THE BAYLEY SCALES OF INFANT DEVELOPMENT AND THE WECHSLER PRESCHOOL AND PRIMARY SCALE OF INTELLIGENCE WITH THE TAIWAN BIRTH COHORT STUDY INSTRUMENT
|
Lung, For-Wey; Chen, Po-Fei; Shu, Bih-Ching |
| 國立臺北護理健康大學 |
2010 |
Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren’s syndrome.
|
林寬佳; Huo, An-Ping;Lin, Kuan-Chia;Chou, Chung-Tei |
| 國立成功大學 |
2012-02 |
Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
|
Chen, Helen H. W.; Yan, Jiang-Jou; Chen, Wen-Chung; Kuo, Macus Tien; Lai, Yu-Hsuan; Lai, Wu-Wei; Liu, Hsiao-Sheng; Su, Wu-Chou |
| 臺大學術典藏 |
2022-08-19T00:21:02Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C. |
| 國立臺灣大學 |
2010 |
Predictive and Prognostic Values of Tau and Ercc1 in Advanced Breast Cancer Patients Treated with Paclitaxel and Cisplatin
|
邵幼雲; 郭冠廷; 胡賦强; 盧彥伸; 黃俊升; 廖肇裕; 許駿; 郭文宏; 張金堅; 林璟宏; 鄭安理; SHAO, YU-YUN; KUO, KUAN-TING; HU, FU-CHANG; LU, YEN-SHEN; HUANG, CHIUN-SHENG; LIAU, JAO-YU; HSU, CHIUN; KUO, WEN-HONG; CHANG, KING-JEN; LIN, CHING -HUNG; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-03-05T07:52:40Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao Y.-Y.; KUAN-TING KUO; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2010 |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Kuo W.-H.; Chiun Hsu; Liau J.-Y.; Lee W.-C.; Huang C.-S.; Lu Y.-S.; Hu F.-C.; Kuo K.-T.; Shao Y.-Y.; Shao Y.-Y.;Kuo K.-T.;Hu F.-C.;Lu Y.-S.;Huang C.-S.;Liau J.-Y.;Lee W.-C.;Chiun Hsu;Kuo W.-H.;Chang K.-J.;Lin C.-H.;Cheng A.-L.; Chang K.-J.; Lin C.-H. |
| 臺大學術典藏 |
2020-05-25T06:52:03Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU |
